Int J Diabetes Dev Ctries. 2010 Jan;30(1):11-7. doi: 10.4103/0973-3930.60004.
Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh.
International journal of diabetes in developing countries
Kjersti Mørkrid, Liaquat Ali, Akhtar Hussain
Affiliations
Affiliations
- Institute of General Practice and Community Medicine, Department of International Health, University of Oslo. Postbox 1130 Blindern, 0318 Oslo, Norway.
PMID: 20431800
PMCID: PMC2859278 DOI: 10.4103/0973-3930.60004
Abstract
AIMS/HYPOTHESIS: The purpose of the study is to estimate the prevalence and risk factors for diabetic peripheral neuropathy (DPN) in type 2 diabetic outpatients at the BIRDEM hospital, Bangladesh.
MATERIALS AND METHODS: Type 2 diabetic outpatients, diagnosed 5-11 years prior to the investigation were randomly selected for the study. DPN was assessed using the Neuropathy Symptom Score (NSS) and Neuropathy Disability Score (NDS). Data about demographics, blood pressure, height, weight, waist and hip circumference, and random blood and urine samples were collected.
RESULTS: Two hundred and ninety four (139 men, 155 women) type 2 diabetic outpatients were studied. The overall DPN prevalence was 19.7 %; male (20.9%), female (18.7 %). The prevalence increased with age (from 11.1% in the 23-40 year-old group to 32.3% in the 60-80 year-old group) and duration of diabetes (from 14.1% in patients with five years to 29.2% in patients with 9-11 years duration). Age > 60 years (OR 4.2, 95% CI 1.4-12.3), low/normal WHR (OR 3.8, 95% CI 1.6-9.3), income < 800 TK (OR 3.1, 95% CI 1.1-9.3) and insulin treatment (OR 2.0, 95% CI 1.0-4.0) were independent, significant risk factors. Longer duration of diabetes (OR1.2 95% CI 1.0-1.4), and higher HbA1c (OR1.1, 95% CI 1.0-1.3) were marginally independent, significant risk factors for DPN.
CONCLUSIONS/INTERPRETATIONS: We observed a DPN prevalence of 19.7%. Higher age, low socioeconomic status, treatment with insulin, longer duration of diabetes and poor glycemic control were risk factors for DPN.
Keywords: Peripheral neuropathy; risk factors; type 2 diabetes
References
- Yonsei Med J. 1999 Feb;40(1):40-5 - PubMed
- Diabetologia. 1993 Feb;36(2):150-4 - PubMed
- Neurology. 1988 Jul;38(7):1161-5 - PubMed
- Diabetologia. 2004 Aug;47(8):1343-53 - PubMed
- Public Health. 2006 Mar;120(3):193-205 - PubMed
- Nephrol Dial Transplant. 2005 Nov;20(11):2402-7 - PubMed
- Eur Neurol. 2007;57(2):91-5 - PubMed
- Med Clin North Am. 2004 Jul;88(4):947-99, xi - PubMed
- Diabetes Care. 2004 May;27(5):1047-53 - PubMed
- Diabetes Care. 2005 Aug;28(8):1869-75 - PubMed
- N Engl J Med. 2005 Jan 27;352(4):341-50 - PubMed
- Acta Neurol Scand. 2006 Dec;114(6):384-91 - PubMed
- Diabet Med. 2002 Feb;19(2):99-104 - PubMed
- Lancet. 2005 Nov 12;366(9498):1719-24 - PubMed
- Med J Malaysia. 2003 Oct;58(4):533-8 - PubMed
- Diabetologia. 1998 Nov;41(11):1263-9 - PubMed
- Diabetes Metab. 2001 Sep;27(4 Pt 1):496-502 - PubMed
- Proc Assoc Am Physicians. 1997 Mar;109(2):181-9 - PubMed
- Diabetologia. 2001 Sep;44 Suppl 2:S65-71 - PubMed
- Diabetes Metab Res Rev. 2004 May-Jun;20 Suppl 1:S19-22 - PubMed
- Diabet Med. 2005 Jul;22(7):931-6 - PubMed
- J Assoc Physicians India. 2002 Apr;50:546-50 - PubMed
- Endocr J. 2004 Dec;51(6):563-7 - PubMed
Publication Types